Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinoma.

The analysis of the prognostic KM curve demonstrated a highly significant difference ( P < 0.001) in the survival outcomes of LUAD patients between the high- and low-risk score groups in the TCGA-LUAD dataset (Fig. 3 E).

also in 132,142 other papers